News

Cielo Denounces Misleading Claims by Expander Energy Inc.

Cielo Denounces Misleading Claims by Expander Energy Inc.

Cielo Takes Bold Stand Against Misleading Claims

Cielo Waste Solutions Corp. (TSXV: CMC; OTC PINK: CWSFF) is firmly addressing a misleading press release recently issued by Expander Energy Inc. The Company passionately defends its position and seeks to clarify its stance for the benefit of its shareholders.

Concerns Over Misleading Information

The core of Cielo's concerns lies in what it perceives as numerous material misstatements present in Expander's release. The Company emphasizes that the inaccuracies were not mere oversights, but deliberate actions that may mislead stakeholders.

Highlighting the Misstatements

One significant issue raised by Cielo is the improper attribution of statements by third parties to the Company. Expander inaccurately represented various opinions as factual assertions, potentially damaging the Company's reputation. Cielo categorically rejects these claims, underlining that they do not align with the facts.

Highlighting Unusual Behavior

Cielo's skepticism extends to what it views as Expander's unusual behavior and intentions. For example, in its press release, Expander raised concerns about financial statements made available months prior, indicating a lack of prior engagement. Such actions lead Cielo to question the motives behind these public disclosures.

Protecting Shareholder Interests

The Company is committed to is protecting its shareholders and maintaining the integrity of its operations. It is taking all necessary steps to counter what it perceives as detrimental behavior from Expander.

Invite for Constructive Dialogue

Ryan C. Jackson, Chief Executive Officer of Cielo, acknowledges the importance of constructive dialogue. Cielo has repeatedly invited Expander and shareholders to collaborate meaningfully for the benefit of all involved.

Reviewing Ongoing Developments

The Company continues to thoroughly review the requisition submitted by Expander, demonstrating its commitment to transparency and shareholder engagement.

Thanking Support from Shareholders

Cielo remains grateful for the ongoing support received from its shareholders amidst these challenges. This support reinforces the Company’s resolve to act in the best interests of all stakeholders.

Legal Advisory and Upcoming Events

In pursuit of safeguarding its interests, Cielo has retained Norton Rose Fulbright Canada LLP as its legal advisor. Furthermore, an upcoming corporate update webinar featuring CEO Ryan C. Jackson will offer insights into the Company's path forward. A new date for this webinar will be communicated shortly.

ABOUT CIELO

Cielo Waste Solutions is at the forefront of transforming waste into valuable renewable fuels. The Company aims to address global environmental challenges while significantly contributing to the circular economy and mitigating carbon emissions. By focusing on innovative, eco-friendly technologies, Cielo uniquely positions itself as a leader in the wood by-product-to-fuels industry. With a mission to change fuels instead of vehicles, Cielo invites investors and stakeholders to join in its commitment to sustainable practices.

Frequently Asked Questions

What is the primary concern Cielo has with Expander's press release?

Cielo argues that Expander's press release is materially misleading, containing misstatements that could harm the Company’s reputation.

How is Cielo protecting its shareholders?

Cielo is taking necessary legal and operational steps to counter the misleading claims and ensure shareholder interests are upheld.

What invitation has Cielo extended to Expander?

Cielo has invited Expander and all shareholders to engage in constructive dialogue for mutual benefit.

Who is Cielo’s legal advisor?

Cielo has retained Norton Rose Fulbright Canada LLP as its legal advisor to navigate these matters.

What is Cielo’s mission?

Cielo is committed to transforming waste into renewable fuels while contributing positively to the environment and the circular economy.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Paulex Bio's PAL-119 Trials: A New Diabetes Frontier

Updated Category News Views 80

Chasing the Holy Grail in Diabetes Treatment The pursuit of a true remedy for diabetes is almost like hunting for the mythical beast—a challenge that's left plenty of contenders biting the dust over the years. Yet, here's Paulex Bio jumping right into the fray with their groundbreaking PAL-119. They're not just peddling another temporary fix like most on the market;...

Continue Reading
PRG Projects' London Studio Elevates Live Entertainment

Updated Category News Views 172

A New Stage for Creativity in London When the curtain rises on a fresh idea, it's often the unknowns that make or break a production. Now, with PRG Projects unveiling their spanking new Project Studio in London, the tech and creative worlds might just bridge their gap tighter than a stage curtain before showtime. London Welcomes PRG's Innovative Hub This isn't just...

Continue Reading
TriMas Streamlines Portfolio with Rapak Sale

Updated Category News Views 48

TriMas Sheds Rapak: A Strategic Move Here's a twist worth dissecting: TriMas Corporation (NASDAQ: TRS) has offloaded its subsidiary Rapak, LLC to the German industrial packaging giant, Ringmetall SE. This isn't just a business shuffle—it's a calculated pivot with eyes on sharpening the core business blade. As they announced from Bloomfield Hills, Michigan, this move...

Continue Reading
i-80 Gold's Q3 2026: Production Plans Unveiled

Updated Category News Views 31

Gold Miners on the Move: Eye on i-80 Wake up and smell the gold, folks. i-80 Gold is ramping up to increase its yearly gold production targets, aiming for a hefty 150,000 to 200,000 ounces by 2028. Now, if you’ve been around the block like me, you know these are the kind of numbers that get investors either shifting in their chairs or springing to their feet. A Brief...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 185

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading
Ascletis Showcases Bold Moves in Obesity Drug Arena

Updated Category News Views 163

If you’ve been watching the developments in the world of obesity treatments, Ascletis Pharma is a name you'd do well not to ignore. With ObesityWeek 2026 on the horizon, these folks aren’t just talking—they’re putting their preclinical cards on the table and they’re noteworthy. Unveiling Future Contenders Ascletis is gearing up to present some of their...

Continue Reading
Lincoln Avenue's Bold New Move: Affordable Senior Living

Updated Category News Views 33

A New Senior Housing Era Begins in Channahon If there's one thing the affordable housing game loves, it's the mix of ambition and grit—both of which Lincoln Avenue Communities (LAC) brings to the table with The Talia. This latest project in Channahon, Illinois, marks their fourth groundbreaking in the state, cementing LAC's place as a key player in providing quality...

Continue Reading
Kim Dunbar Sheds Light on Online Personalized Learning

Updated Category News Views 11

Picture a classroom without walls, the teacher always available, and students moving at their own pace. Sounds utopian, right? Well, Virtual Public School Expert Kim Dunbar is making sense of this approach at SC Whitmore School in Columbia, South Carolina, as she explains how this works in an online high school. Mastery-Based Learning: Beyond the Conventional Rigid...

Continue Reading
Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026

Updated Category News Views 23

Neurocrine's Triple-Digit Surge Neurocrine Biosciences is on a tear, pushing its revenue up to a jaw-dropping $1.1 billion in Q3 2026—a hefty 41% leap from the previous year. Frankly, you can't ignore those numbers. INGREZZA, which is practically becoming a cash cow, did $801 million alone, rising 17% year over year. This rides the wave of prescription surges and solid...

Continue Reading
Dr. Huang's Honorary Degree Caps Global Impact Journey

Updated Category News Views 41

Recognition from Alma Mater Puts a Bow on a Storied Career When someone ventures out into the world and leaves a mark across continents, it’s a remarkable feat. It’s even more heartening when the place that helped shape them gets to extend a nod of recognition. Dr. Charles Huang, the mastermind behind Pasaca Capital, just unwound a new layer to his multicolored life...

Continue Reading
/neurocrine-biosciences-hits-1-billion-mark-in-q3-2026-540185-/" title="Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026 - Continue Reading" aria-label="Continue reading: Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026"> Continue Reading